Powder: -20°C for 3 years | In solvent: -80°C for 1 year
XMD-17-51 Trifluoroacetate 是可调控蛋白激酶的嘧啶-安定酮化合物。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 669 | 现货 | ||
2 mg | ¥ 987 | 现货 | ||
5 mg | ¥ 1,650 | 现货 | ||
10 mg | ¥ 2,650 | 现货 | ||
25 mg | ¥ 4,350 | 现货 | ||
50 mg | ¥ 6,150 | 现货 | ||
100 mg | ¥ 8,280 | 现货 | ||
500 mg | ¥ 16,500 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,890 | 现货 |
产品描述 | XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound that regulates protein kinases. |
体外活性 | XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound that is able to modulate protein kinases, including MPS1 (TTK), ERK5 (BMK1, MAPK7), polo kinase 1, 2, 3, or 4, Ack1, Ack2, Abl, DCAMKL1, ABL1, Abl mutants, DCAMKL2, ARK5, BRK, MKNK2, FGFR4, TNK1, PLK, ULK2, PLK, PRKD1, PRKD2, PRKD3, ROS1, RPS6KA6, TAOK1, TAOK3, TNK2, Bcr-Abl, GAK, cSrc, TPR-Met, Tie2, MET, FGFR3, Aurora, Axl, Bmx, BTK, c-kit, CHK2, Flt3, MST2, p70S6K, PDGFR, PKB, PKC, Raf, ROCK-H, Rsk1, SGK, TrkA, TrkB and TrkC. XMD-17-51 Trifluoroacetate can be used in the treatment of various diseases, disorders or conditions [1]. |
别名 | XMD-17-51 Trifluoroacetate (1628614-50-5 free base) |
分子量 | 518.49 |
分子式 | C23H25F3N8O3 |
CAS No. | 2436579-93-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 8 mg/ml (19.78 mM)
H2O: 2 mg/ml (4.94 mM)
DMSO: 80 mg/ml (197.78 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / H2O / DMSO | 1 mM | 1.9287 mL | 9.6434 mL | 19.2868 mL | 48.2169 mL |
Ethanol / DMSO | 5 mM | 0.3857 mL | 1.9287 mL | 3.8574 mL | 9.6434 mL |
10 mM | 0.1929 mL | 0.9643 mL | 1.9287 mL | 4.8217 mL | |
DMSO | 20 mM | 0.0964 mL | 0.4822 mL | 0.9643 mL | 2.4108 mL |
50 mM | 0.0386 mL | 0.1929 mL | 0.3857 mL | 0.9643 mL | |
100 mM | 0.0193 mL | 0.0964 mL | 0.1929 mL | 0.4822 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
XMD-17-51 Trifluoroacetate 2436579-93-8 Chromatin/Epigenetic PI3K/Akt/mTOR signaling AMPK XMD-17-51 Trifluoroacetate (1628614-50-5 free base) 1628614-50-5 1628614-50-5 free base XMD 17 51 Trifluoroacetate XMD1751 Trifluoroacetate Inhibitor inhibitor inhibit